CW
VKTX icon

Curio Wealth’s Viking Therapeutics VKTX Stock Holding History

Curio Wealth’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-279
Closed -$9.08K – 1110
2026
Q1 		$9.08K Hold
279
– – ﹤0.01% 224
2025
Q4 		$10.4K Hold
279
– – ﹤0.01% 243
2025
Q3 		$7.33K Buy
+279
New +$8.32K ﹤0.01% 198
2025
Q2 		– Sell
-1
Closed -$13.5K – 400
2025
Q1 		$13.5K Buy
+1
New +$32 0.01% 212

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Curio Wealth's VKTX Position: Q2 2026 in Review

Curio Wealth sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 279 shares — an estimated $9.08K sold.

Curio Wealth first reported a position in VKTX in Q1 2025 and held it in 4 quarters. The position peaked at $13.5K in Q1 2025. 434 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Curio Wealth reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 279 Viking Therapeutics shares in Q2 2026, an estimated $9.08K.
  • Curio Wealth first reported a position in Viking Therapeutics in Q1 2025 and held it in 4 quarters.
  • Curio Wealth's Viking Therapeutics position peaked at $13.5K in Q1 2025.
  • 434 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.